Showing posts with label screening. Show all posts
Showing posts with label screening. Show all posts

Sunday, November 4, 2012

More than half of hospitals don’t screen all ICU patients for MRSA


More than half of hospitals don’t screen all ICU patients for MRSA


By KEVIN B. O'REILLY, amednews staff. Posted Oct. 31, 2012.

MRSA and other multidrug-resistant organisms account for most hospital infections. State-mandated screening may prove ineffective.

The majority of hospitals are eschewing aggressive, time-consuming and costly interventions that might help prevent the spread of multidrug-resistant organisms such as methicillin-resistant Staphylococcus aureus.
Forty percent of infection-control directors said their intensive care units screen all newly admitted patients for multidrug-resistant organisms, according to a study in the October American Journal of Infection Control. About 30% of ICUs do such screening periodically, said the study, based on a nationwide survey of infection-control directors at 250 hospitals operating 413 ICUs.
An estimated 70% of bacteria that cause health care-associated infections are resistant to at least one antibiotic, the study said. Patients with staph infections, vancomycin-resistant Enterococcus or Clostridium difficile are 40% likelier to be readmitted within a year than other patients, said a study in June’s Infection Control and Hospital Epidemiology (ncbi.nlm.nih.gov/pubmed/23021413/).

Does universal screening help?

Whether so-called universal screening of high-risk patients can help slash the toll of multidrug-resistant organisms has been hotly debated. At least 10 states mandate such screening. A study about a randomized trial published in the April 14, 2011, issue of The New England Journal of Medicine found that screening ICU patients for MRSA and VRE had no impact on infection rates after six months (ncbi.nlm.nih.gov/pubmed/21488763/).
However, contact precautions such as wearing gloves and gowns when caring for patients colonized with these bacteria were employed only after their test results came back positive, which takes days. Experts say it is possible that the delay in taking precautions diminished the effect of universal screening.
The Society for Healthcare Epidemiology of America opposes mandatory universal screening for antibiotic-resistant organisms. The organization supports the policy of taking contact precautions and isolating high-risk patients while their test results are pending. Only 31% of ICUs implement such a policy, said theAJIC study.
Until stronger evidence emerges of a clear benefit from universal screening, infection-control directors should evaluate their local circumstances when deciding how to proceed, said Monika Pogorzelska-Maziarz, PhD, MPH, the study’s lead author.
“It’s difficult to recommend infection-control policies that will work across all hospitals,” said Pogorzelska-Maziarz, associate research scientist at the Columbia University School of Nursing in New York City. “Hospitals might not have the resources to do universal screening, so focusing on patients we know are at high risk seems to be a good idea.”

MRSA Strategy in ICU Cuts All Infections


MRSA Strategy in ICU Cuts All Infections


By Ed Susman, Contributing Writer, MedPage Today

Published: October 18, 2012

Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania and Dorothy Caputo, MA, BSN, RN, Nurse Planner


SAN DIEGO – Bathing all patients in the ICU with antibacterial agents rather than simply screening for methicillin-resistant Staphylococcus aureus (MRSA) reduced all bloodstream infections by more than 40%, researchers said here.
In a study conducted at 43 hospitals, universal treatment – without screening – cut MRSA colonization by 37% and resulted in a 44% reduction in all bloodstream infections, said Susan Huang, MD, MPH, associate professor of infectious diseases at the University of California, Irvine School of Medicine.
That compared with essentially no difference in reduction of infections when patients were given the standard-of-care treatment of screening and isolation, Huang said at a press briefing during IDWeek 2012.
Huang also said that universal treatment without screening proved more effective than screening, followed by washing patients with chlorhexidine and using mupirocin to decolonize MRSA in the nose. That strategy was 22% better than the standard of care , but universal treatment was better than screening first then treating ), she said.
"I am pleased to say that on the basis of this study, Hospital Corporation of America has adopted the universal strategy for treating patients in ICU at their 160 facilities," Huang told MedPage Today.
"This study is compelling enough to change standard practice of screening and isolation," briefing moderator Daniel Diekema, MD, professor of medicine and director of infectious diseases at the University of Iowa, Iowa City, told MedPage Today. He was not involved in the study.
Huang noted, "This trial provides strong evidence that removing bacteria from the skin and nose is highly effective at preventing serious infection in high-risk ICU patients. 
Article Concluded: Med Page Today

Tuesday, August 28, 2012

Review of a major epidemic of methicillin resistant Staphylococcus aureus: The costs of screening and consequences of outbreak management.


Review of a major epidemic of methicillin resistant Staphylococcus aureus: The costs of screening and consequences of outbreak management.

Aug 2012

Source

Molecular Diagnostics Unit, Maasstad Hospital, Rotterdam, The Netherlands.

Abstract 


BACKGROUND:

A major outbreak of methicillin-resistant Staphylococcus aureus (MRSA) occurred in locations C and Z of our hospital and lasted for several years. It affected 1,230 patients and 153 personnel.

METHODS:

Outbreak management was installed according to the Dutch "search and destroy" policy. A rapid, high-throughput method for molecular screening of potential MRSA carriers was implemented. Outbreak isolates were retrospectively genotyped by pulsed field gel electrophoresis. Costs of molecular screening were compared with screening by culture.

RESULTS:

Genotyping results revealed 4 distinct epidemic MRSA clones. Three were present in hospital C. Because of a merger of hospitals, these clones spread to hospital Z. Another clone of MRSA affected other health care-related institutions in the region. Because of the implementation of strict containment measures of the "search and destroy" policy, the annual number of tests decreased from 100,000 to 18,000. The disposables and reagents used in polymerase chain reaction technology are more expensive than those of conventional methods. However, the clinical and economic benefits of fast results in regard to expenses of the hospital clearly outweigh the higher costs of screening.

CONCLUSION:

The implementation of a rapid, high-throughput molecular screening system greatly contributed to the effectiveness of strict containment measures of the "search and destroy" policy. The major epidemic clones of MRSA in the outbreak were eradicated by this strategy.

Thursday, February 9, 2012

Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus

Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study.


Feb 2012

ABSTRACT:


INTRODUCTION:


Pre-emptive isolation of suspected methicillin-resistant Staphylococcus aureus (MRSA) carriers is a cornerstone of successful MRSA control policies. Implementation of such strategies is hampered when using conventional cultures with diagnostic delays of 3 to 5 days, as many non-carriers remain unnecessarily isolated. Rapid diagnostic testing (RDT) reduces the amount of unnecessary isolation days, but costs and benefits have not been accurately determined in intensive care units (ICUs).


METHODS:


Embedded in a multi-centre hospital-wide study in 12 Dutch hospitals we quantified cost per isolation day avoided using RDT for MRSA, added to conventional cultures, in ICUs. BD GeneOhmTM MRSA PCR (IDI) and Xpert MRSA(GeneXpert) were subsequently used during 17 and 14 months, and their test characteristics were calculated with conventional culture results as reference. We calculated the number of pre-emptive isolation days avoided and incremental costs of adding RDT.


RESULTS:


163 patients at risk for MRSA carriage were screened and MRSA prevalence was 3.1% (n=5). Duration of isolation was 27.6 and 21.4 hours with IDI and GeneXpert, respectively, and would have been 96.0 hours when based on conventional cultures. The negative predictive value was 100% for both tests. Numbers of isolation days were reduced by 44.3% with PCR-based screening at the additional costs of E327.84 (IDI) and E252.14 (GeneXpert) per patient screened. Costs per isolation day avoided were E136.04 (IDI) and E121.76 (GeneXpert).


CONCLUSIONS:


In a low endemic setting for MRSA, RDT safely reduced the number of unnecessary isolation days on ICUs by 44%, at the costs of E121.76 to E136.04 per isolation day avoided.


PubMed

Sunday, October 11, 2009

MRSA survivors say screening is key

MRSA survivors say screening is key

Special to the Tribune

October 7, 2009

Ken Reimer's activism began when his infant daughter, Madeline, died after contracting a mysterious illness.

In Jeanine Thomas' case, doctors almost amputated her leg. Debbie Holsten spent nearly $150,000 recovering from a superbug.

This month, Reimer, Thomas and Holsten are speaking up about the dangerous bacterium that caused them so much pain. They are among a passionate group of local activists urging more action to stem the spread of methicillin-resistant Staphylococcus aureus, or MRSA.

MRSA survivors gathered last week at Loyola University's downtown campus to observe the first-ever World MRSA Day, which kicked off MRSA Awareness Month to spread the word about a dangerous infection.


"It shatters people's lives," said Thomas, a Willowbrook resident who is founder of the MRSA Survivors Network and was bedridden for months while recovering from the damage caused by MRSA.

"The media and the government like the disease du jour," said Dr. William Jarvis, an
Oregon-
based infectious disease specialist who has studied the spread of MRSA. "I think the time has come for our government to spend sufficient resources to stop MRSA infections."

When compared with much-publicized diseases such as SARS and swine flu, Jarvis and others say the dangers of MRSA demand a stronger response.

The federal Centers for Disease Control and Prevention consider MRSA a "major public health problem" and estimate that 19,000 people die from MRSA in the United States each year. Fewer than 15,000 die annually from HIV/AIDS.

MRSA first appeared in American hospitals in the late 1970s, and the threat has grown exponentially since then. The disease comes in two forms: community-associated MRSA and the more common hospital-associated disease. MRSA is contracted by contact with items where the bug may reside, such as playgrounds, medical utensils, doctors' jackets or even other people's skin. It often enters the body through cuts or during surgery.

MRSA is tougher to treat than other staph infections because it is resistant to many antibiotics, as the name suggests. It's unclear how widespread the problem is in
Chicago and Illinois, but 1.2 million MRSA infections were documented nationwide in 2006.

Illinois was the first state to require hospitals to report infection rates, but the state health department has yet to release the numbers. At least 25 other states publish the data. A Web site with statistics from 2008 is expected to launch sometime this month, said Illinois Department of Public Health spokeswoman Kelly Jakubek.

State legislation mandates that all hospitals screen at-risk patients and those entering intensive care units, but Thomas said all patients should be screened.

"It's about saving lives," she said. Thomas said she may push for broader legislation for MRSA screening.

At Loyola University Hospital in Maywood, where all patients have been screened since late 2007, the number of hospital-associated MRSA cases has dropped by two-thirds, said Dr. Jorge Parada, associate professor of medicine, infectious diseases, at the
Loyola University Chicago Stritch School of Medicine.

Parada said Loyola saw a 566 percent jump in patients coming to the emergency room with MRSA from 2000 to 2007 and, once it began universal screening, found one in every 14 patients was already colonized with MRSA upon admission. Those found to be infected are isolated and treated.

"Without looking for MRSA, all we see is the tip of the iceberg," he said.

Still, activists' efforts won't bring Reimer's daughter back.

MRSA devastated Reimer and his wife, Beth. The
Batavia couple lost their newborn, Madeline, to the disease. A second daughter, Emma, was diagnosed with the bacterium shortly after her birth but survived.

"We were trying to figure out how a healthy baby girl dies from something we've never heard of, a superbug," Reimer said. "These are two babies that didn't do anything wrong."

Chicago Tribune Health